Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -72.77 | 8.13 |
| PEG Ratio (TTM) | 0.03 | 0.27 |
| P/S Ratio (TTM) | 0.71 | 2.84 |
| P/B Ratio (TTM) | 0.64 | 1.61 |
| P/FCF Ratio (TTM) | 22.93 | 39.22 |
| Price to 5YR AVG Earnings Ratio | 32.51 | 15.84 |
| Price to 5YR AVG FCF Ratio | 7.99 | 32.96 |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.02% | 8.04% |
| ROE (TTM) | -0.83% | 17.09% |
| Net Profit Margin (TTM) | -0.59% | 30.29% |
| ROIC 5YR AVG | 1.26% | 6.51% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 28.15% | 443.60% | 248.70% |
| Revenue | -12.28% | 98.91% | 68.85% |
| Net Income | 33.91% | 510.09% | 291.60% |
| Cash Flow | -39.94% | 403.46% | 279.88% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 23.71 |
| Quick Ratio (TTM) | N/A | 22.52 |
| D/E Ratio (TTM) | 0.54 | 0.22 |
| Interest Coverage (TTM) | N/A | 10.35 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.11 | 2.63 |
| LTL to 5YR AVG FCF | 4.26 | 4.56 |
| Shares Outstanding Growth 5YR AVG | -5.85% | -2.58% |